IP Library Assignment 059183/0481
Patent Assignment
Reel/Frame 059183/0481

Assignment of Assignor's Interest

Recorded: 2022-03-07 Pages: 7
Assignor
MEDIMMUNE, LLC
Executed: 2018-02-23
Assignee
VIELA BIO, INC.
ONE MEDIMMUNE WAY, FIRST FLOOR, AREA TWO, GAITHERSBURG, MARYLAND, 20878
Covered Property (1)
Antibodies to Feline Mcdonough Sarcoma (Fms)-Like Tyrosine Kinase 3 Receptor Ligand (FLT3L) and Uses Thereof for Treating Autoimmune and Inflammatory Diseases
Application: 16/969,774 →
Publication: US 2021/0002360
Related Assignments (4)
Other recorded transfers of the patent in this record — the chain of ownership.
Security Agreement Mar 15, 2021
From: HORIZON ORPHAN LLC; HORIZON THERAPEUTICS USA, INC.; VIELA BIO, INC.
To: CITIBANK, N.A.
Reel/Frame 055659/0430 →
Assignment of Assignor's Interest Mar 7, 2022
From: HANSEN, ANNA; XIAO, XIAODONG; PAVLIK, PETER; CHEN, YAN
To: VIELA BIO, INC.
Reel/Frame 059183/0491 →
Release of Security Interest Oct 6, 2023
From: CITIBANK, N.A.
To: HORIZON THERAPEUTICS U.S. HOLDING LLC (FKA HORIZON ORPHAN LLC); HORIZON THERAPEUTICS USA, INC.; VIELA BIO, INC.
Reel/Frame 065154/0064 →
Assignment of Assignor's Interest May 22, 2024
From: VIELA BIO, INC.
To: HORIZON THERAPEUTICS IRELAND DAC
Reel/Frame 067489/0445 →